Chemical interference with DSIF complex formation lowers synthesis of mutant huntingtin gene products and curtails mutant phenotypes.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35914128.
- Also identified by DOI 10.1073/pnas.2204779119 and PMC identifier 9371670.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Earlier work has shown that siRNA-mediated reduction of the SUPT4H or SUPT5H proteins, which interact to form the DSIF complex and facilitate transcript elongation by RNA polymerase II (RNAPII), can decrease expression of mutant gene alleles containing nucleotide repeat expansions differentially. Using luminescence and fluorescence assays, we identified chemical compounds that interfere with the SUPT4H-SUPT5H interaction and then investigated their effects on synthesis of mRNA and protein encoded by mutant alleles containing repeat expansions in the huntingtin gene (<i>HTT</i>), which causes the inherited neurodegenerative disorder, Huntington's Disease (HD). Here we report that such chemical interference can differentially affect expression of <i>HTT</i> mutant alleles, and that a prototypical chemical, 6-azauridine (6-AZA), that targets the SUPT4H-SUPT5H interaction can modify the biological response to mutant <i>HTT</i> gene expression. Selective and dose-dependent effects of 6-AZA on expression of <i>HTT</i> alleles containing nucleotide repeat expansions were seen in multiple types of cells cultured in vitro, and in a <i>Drosophila melanogaster</i> animal model for HD. Lowering of mutant HD protein and mitigation of the <i>Drosophila</i> "rough eye" phenotype associated with degeneration of photoreceptor neurons in vivo were observed. Our findings indicate that chemical interference with DSIF complex formation can decrease biochemical and phenotypic effects of nucleotide repeat expansions.
Medical subject headings
- Azauridine
- Huntingtin Protein
- Huntington Disease
- Mutant Proteins
- Mutation
- Nuclear Proteins
- Phenotype
- Repressor Proteins
- Transcriptional Elongation Factors